In the nearly two years since the pandemic began, there isn’t one treatment or even any specific diagnosis for the many people with persistent or new symptoms after an infection.
The affliction continues to confound the medical establishment. Long-haulers are men and women of all ages who had all levels of COVID severity.
The clinic serves hundreds and many improve over time. Others continue to have fatigue, brain fog or shortness of breath, among more serious conditions. Many also have anxiety or depression. “This is really the tough one,” he said of the last bucket. “We’re not turning to a textbook and seeing it. An example is fatigue: What’s causing that?”
“The first step is saying, ‘Hey, it’s real. We believe you,’” she said. “The second stage is determining what we know about it, what we can learn about it and how we can treat it.”and aim to collect information from 25,000 people across the country. They are about halfway there. Another larger study sponsored by the National Institutes of Health launched in June and is called RECOVER. It will involve 100 researchers at more than 30 institutions and aims to reveal trends and inform new approaches to diagnosis and treatment.
About 10% have suffered more than a year, said Levine, a pulmonary and critical care specialist at the Baltimore hospital and an assistant professor in the University of Maryland School of Medicine.Levine also doesn’t know how many patients never came in for lingering issues either because they didn’t know they had COVID-19 or never bothered to seek care.
“I don’t know what causes that,” she said. “Thankfully, one thing we do know is completing a two-dose regimen of vaccine seems protective against long COVID.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Coronapod: How African scientists are copying Moderna's COVID vaccinePharmaceutical companies have declined to license their COVID vaccines, so South African scientists have copied them instead
続きを読む »
FDA authorizes new Covid antibody drug to fight omicron variantThe FDA has cleared a new antibody drug, that targets the omicron variant, for adults and adolescent patients with mild-to-moderate cases.
続きを読む »
5 Things COVID Experts Need To See Before They'll Go Maskless At The OfficeAs more states relax mask mandates, epidemiologists and other experts reveal when they'll feel comfortable taking off their mask at work.
続きを読む »
FDA Committee Delays Review of Pfizer-BioNTech's COVID-19 Vaccine for Young ChildrenFDA Committee Delays Review of Pfizer-BioNTech's COVID-19 Vaccine for Young Kids
続きを読む »
COVID-19 Can Destroy Placenta, Lead to StillbirthsNew research suggests the coronavirus can invade and destroy the placenta and lead to stillbirths in infected women.
続きを読む »
Illinois gubernatorial candidates debate Covid-19 pandemic policyShe's a political rival of Republican candidate for governor Darren Bailey. State representative Avery Bourne called him a flip-floppper on pandemic policy.
続きを読む »